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Background: Esophageal cancer is one of the most serious gastrointestinal cancer worldwide, owing to its rapid
development and fatal prognoses in most cases. There is a paucity of published data regarding esophageal cancer
in Tanzania and the study area in particular. This study was conducted to describe the endoscopic and
clinicopathological patterns of esophageal cancer in this part of the world. The study provides baseline local data
for future comparison.
Methods: This was a retrospective study of histologically confirmed cases of esophageal cancer seen at Bugando
Medical Center and Muhimbili National Hospital between March 2008 and February 2013. Data were retrieved from
medical record computer database and analyzed using SPSS computer software version 17.0.
Results: A total of 328 esophageal cancer patients were enrolled in the study, representing 25.3% of all malignant
gastrointestinal tract tumors. The male to female ratio was 2.2:1. The median age of patients at presentation was 47
years. The majority of patients (86.6%) were peasants coming from the rural areas. Smoking and alcohol
consumption were documented in 74.7% and 61.6% of patients respectively. Family history of esophageal cancer
was reported in 4.6% of cases. The majority of patients (81.7%) presented late with advanced stage of cancer.
Progressive dysphagia and weight loss were the most common presenting symptoms occurring in all patients. The
middle third esophagus (58.5%) was the most frequent anatomical site for esophageal cancer followed by lower
third (27.4%) and upper third esophagus (10.4%). Squamous cell carcinoma (96.0%) was the most common
histopathological type. Adenocarcinoma occurred in 13 (4.0%) patients. TNM staging was documented in only 104
(31.7%) patients. Of these, 102(98.1%) patients were diagnosed with advanced esophageal cancer (Stages III and IV).
According to tumor grading, most of tumors were moderately differentiated accounting for 56.1% of cases. Distant
metastasis was documented in 43.3% of patients.
Conclusion: Esophageal cancer is not uncommon in this region and shows a trend towards a relative young age
at presentation and the majority of patients present late with advanced stage. There is a need for screening of
high-risk populations and detecting esophageal cancer at an early stage in order to improve chances for successful
treatment and survival.
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Esophageal cancer is one of the most serious tumors
worldwide, owing to its rapid development and fatal
prognosis in most cases [1]. Worldwide, esophageal can-
cer ranks eighth in cancer incidence and sixth in cancer
mortality [2,3]. The incidence of esophageal cancer var-
ies widely, and certain areas such as northern China
[1,3], northeastern Iran [4], and South Africa [5] have
very high rates of this disease, with age-standardized
incidence rates from 50 to over 100 cases per 100,000
population per year. In contrast, most Western countries
have much lower incidence rates of esophageal cancer,
from 4 to 10 cases per 100,000 population per year [5].
Epidemiological studies have identified tobacco, con-
sumption of maize contaminated by Fusarium verticil-
loides and nitrosamine as well as human papillomavirus
(HPV) infection as risk factors associated with the devel-
opment of cancer of the esophagus [6-8]. Tobacco and
HPV infection have been associated with non-endemic
esophageal cancer while the endemic cancer has been
associated with maize meal, which is used as staple food,
due to contamination by fungal mycotoxins, as well as
nutritional deficiencies [9,10]. The risk of esophageal
cancer increases with constant exposure to stimulants,
hot beverages, alcohol and smoking. It has higher inci-
dence in societies with low economic status, severe mal-
nutrition, low vitamin, fruit and vegetable intake, and
also high consumption of alcohol and cigarettes. The
unchangeable factors in this cancer include age, sex and
hereditary background. In various studies conducted in
China, relative risk of patients with a family history of
esophageal cancer was around 2.9% of cases [11]. Its pre-
vention is based on early detection and surveillance of pre-
cancerous lesions, especially of Barrett’s esophagus, and
attention should also focus on modification of changeable
risk factors, including tobacco smoking, alcohol abuse,
and ingestion of hot and spicy food. The occurrence of
esophageal cancer increases with age with the highest inci-
dence in the age group 50 to 70 years. The disease is diag-
nosed more frequently in male than in female patients
with an approximate ratio of 3-to-5:1 [12].
There are two main histological types; squamous cell
carcinoma and adenocarcinoma. Worldwide, squamous
cell carcinoma is the predominant histological type [13].
The peak age of incidence of squamous cell carcinoma is
in the sixth decade in most studies, although adenocar-
cinoma appears to be commoner in males under the age
of 40 years [12]. Worldwide, a higher incidence of
esophageal cancer is seen in men with an average 3- to
4-fold increased rate for squamous cell carcinoma and a
7- to 10-fold increased rate for adenocarcinoma com-
pared to women [12,13]. There is racial variation in the
histological types with predominance of squamous cell
carcinoma in black populations, representing over 90%of all esophageal cancers in Africa [14-16]. Adenocarcin-
oma is the predominant type in Western countries [13].
In the US, adenocarcinoma of the esophagus is reported
to be the most common malignancy with the fastest
growing incidence, having increased six times in three
decades [13,16].
The middle third of the esophagus is the commonest
site for squamous cell carcinoma and the lower third is
the commonest site for adenocarcinoma [12,14-16].
Most patients present with progressive dysphagia and
weight loss with dysphagia being the most important
and the first symptom. As most patients present at ad-
vanced stage, mortality is very high and even with oper-
able tumors, postoperative mortality is about 50% [17].
The symptoms of esophageal cancer usually appear 3 to
4 months prior to diagnosis and such symptoms vary de-
pending on the segment of esophagus initially involved.
Dysphagia is the most common symptom occurring in
more than 90% of cases; weight loss over 5 to 10% of
body weight occurs in the major ity of patients and is
associated with a worse prognosis [18]. Less common
symptoms, such as hoarseness, cough and progressive le-
sions with invasion to other organs result in symptoms
such as hematemesis, hemoptysis, dyspnea and cough
secondary to bronchoesophageal and tracheoesophageal
fistula [17,18].
The clinical stage of the disease at presentation is im-
portant for the outcome of the patient with esophageal
cancer. However, the outcome of treatment of esopha-
geal cancer in our environment has been poor because
the majority of patients present late to the hospital with
an advanced stage and only palliative care is possible.
This is partly due to the paucity of published local data
regarding this condition and lack of community aware-
ness on the importance of early reporting to hospital for
early diagnosis and treatment.
The pattern of esophageal cancer is rapidly changing
worldwide. In Western countries, adenocarcinoma of the
lower esophagus has overtaken the previously more
prevalent squamous cell carcinoma [13]. This observa-
tion makes it essential that studies are made periodically
in every region to describe the patterns of this disease
with the idea to do work on their prevention. It is with
this background that the authors were prompted to
analyze this problem. This study was conducted to de-
scribe the endoscopic and clinicopathological character-
istics of esophageal cancer in two tertiary care hospitals
in Tanzania and compare our results with what is seen
in Western countries. The study provides baseline local
data for future comparison.
Methods
This was a retrospective study of patients with histo-
logical diagnosis of esophageal cancer seen at Bugando
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tween March 2008 and February 2013. Bugando Medical
Centre is situated along the shore of Lake Victoria in
northwestern Tanzania. It is a tertiary care and teaching
hospital for the Catholic University of Health and allied
Sciences-Bugando (CUHAS-Bugando) and has a bed
capacity of 1,000. It serves as a referral center for tertiary
specialist care for a catchment population of approxi-
mately 13 million people in northwestern Tanzania.
Muhimbili National Hospital is located in the capital city
of Dar es Salaam and is the largest hospital in the coun-
try with a bed capacity of 1,500. The hospital serves as a
national referral hospital and a teaching hospital for
Muhimbili University of Health and allied Sciences and
other paramedical staff.
The study population included all patients who
presented to Bugando Medical Centre with histologically
confirmed esophageal cancer during the period studied.
Patients with incomplete data were excluded from the
study. The details of patients were retrieved from the
computer database of the hospital located in the medical
record department and histopathology laboratory. Infor-
mation was collected using a preformed questionnaire.
Included in the questionnaire were questions on socio-
demographic data, clinical presentation, anatomical site,
gross appearance, tumor, node, metastasis (TNM) sta-
ging, histopathological type and grade, and presence of
metastasis. The severity of dysphagia was graded as fol-
lows: grade 1: normal swallowing; grade 2: difficulty in
swallowing solids; grade 3: difficulty in swallowing semi-
solids; grade 4: difficulty in swallowing liquids; grade 5:
difficulty in swallowing own saliva.
The clinical staging was performed using TNM (American
Joint Committee on Cancer (AJCC) cancer staging manual);
this is a staging system that is an expression of the anatom-
ical extent of the disease based on the extent of the primary
tumor (T), absence or presence of and extent of regional
lymph node metastasis (N) and absence or presence of dis-
tant metastasis (M) [19].
The diagnosis of esophageal cancer was performed by
barium swallow and fiberoptic or rigid esophagoscopy
and confirmed pathologically by esophagoscopic biop-
sies. Chest radiographs, abdominal ultrasound, and
computed tomography (CT) of the chest and abdomino-
pelvic region were performed whenever necessary to
exclude distant metastasis. Endoscopic ultrasound (EUS)
was not performed due to lack of this facility at our
centre. Other routine laboratory investigations included
full blood picture, serum creatinine, serum electrolytes
and serum liver function tests.
Statistical data analysis
Statistical data analysis was done using SPSS software
version 17.0 (SPSS, Inc, Chicago, IL, USA). Data weresummarized in the form of proportions and frequency
tables for categorical variables. Continuous variables
were summarized using means, median, mode and
standard deviation. P-values were computed for categor-
ical variables using the Chi-square (χ2) test and the
Fisher exact test, depending on the size of the dataset.
The independent Student t-test was used for continuous
variables. A P-value less than 0.05 was considered to
constitute a statistically significant difference.
Ethical consideration
Ethical approval to conduct the study was obtained from
the CUHAS/Bugando Medical Centre/MUHAS Joint
Institutional Ethic Review Committee before the com-
mencement of the study.
Results
During the period of study, a total of 1,296 malignant
gastrointestinal tract tumors were registered at Bugando
Medical Center and Muhimbili National Hospital. Of
these, 328 patients, representing 25.3% of all cases, were
histopathologically confirmed cases of esophageal cancer
and formed the study population. The age of patients at
presentation ranged from 24 to 78 years with a median
age of 47 years. The modal age group was 41 to 50 years;
158 (48.2%) patients were aged 50 years or below. There
were 226 (68.9%) men and 102 (31.1%) women with a
male to female ratio of 2.2:1. The difference in mean age
between men and women at presentation was not statis-
tically significant (P = 0.456). The majority of patients
(n = 284, 86.6%) were peasants coming from the rural
areas and most of them, (n = 249, 75.9%) were un-
employed. The vast majority of patients (n = 292,
89.0%), had either primary education only or no formal
education, and more than 80% of patients belonged to
low socioeconomic status (Table 1).
The duration of symptoms ranged from 2 to 14
months with a median duration of 4 months. The major-
ity of patients (n = 268, 81.7%) had experienced symp-
toms for 1 to 4 months by the time of presentation. All
the patients presented with progressive dysphagia
(graded as shown in Table 2) and weight loss (100%);
249 patients (75.9%) presented with regurgitation, and
102 (31.1%), 45 (13.7%) and 12 (3.7%) patients presented
with retrosternal pain, odynophagia and hematemesis,
respectively. Symptoms related to distant metastasis
were recorded for 135 (41.2%) patients. Smoking and al-
cohol consumption were reported by 245 (74.7%) and
202 (61.6%) patients, respectively. There was no history
of drug addiction. Family history of esophageal cancer
was reported by 15 (4.6%) patients.
The middle third of the esophagus was the most fre-
quent anatomical site for esophageal cancer in 58.5% of
patients. This was followed by the lower third of the
Table 1 Distribution of patients according to their
characteristics
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and 10.4% of patients, respectively. The anatomical site
was not recorded in 3.7% of patients. On endoscopic
examination, most of lesions were ulcerative (40.2%).
The median tumor length according to endoscopy and
barium swallow was 5 cm (range 4 to 7 cm). The tumorTable 2 Distribution of patients according to the grade of
dysphagia






Total 328 100length was ≤5 cm in 40.2% of patients and >5 cm in 185
(52.4%) patients. The tumor length was not documented
in 11 (3.4%) patients. Squamous cell carcinoma was the
most common histopathological type, occurring in 315
(96.0%) patients. Of these, 34 (10.8%) tumors were in
the upper third, 200 (63.5%) in the middle third and 81
(25.7%) in the lower third. Adenocarcinoma occurred in
13 (4.0%) patients, of which 9 (69.2%) were in the lower
third and 4 (30.8%) in the middle third. Out of 13
patients with adenocarcinoma, 3 (23.1%) patients had
evidence of Barrett’s esophagus. TNM staging was docu-
mented in only 104 (31.7%) patients. Of these, 102
(98.1%) patients were diagnosed with advanced esopha-
geal cancer (stages III and IV). According to tumor
grading, most of tumors were moderately differentiated,
accounting for 56.1% of cases. Distant metastasis was
documented in 43.3% of patients (Table 3).
Discussion
In this review, colorectal cancer accounted for 25.3% of
all malignant gastrointestinal tumors seen during the
study period. This figure is significantly higher than the
9.5 to 13.3% recorded in previous studies from Nigeria
[20,21]. A high figure of 32.5% was recorded in Addis
Ababa [16]. Differences in exposure to several risk fac-
tors for esophageal cancer may be responsible for this
regional variation. Our figure for esophageal cancer in
this study may actually be underestimated by the retro-
spective nature of the study. A better picture of the
incidence of esophageal cancer in this region requires
prospective comprehensive data collection.
In keeping with other studies [16,20,21], the peak age
incidence of esophageal cancer in this study was found
to be in the fourth decade of life, which is about a dec-
ade or two earlier compared to the findings in developed
countries [3,22,23]. The presence of a high number of
young patients with esophageal cancer in our setting ne-
cessitates family screening since genetic factors may play
an important role in the development of this disease.
This makes early detection and management an import-
ant measure in order to reduce the incidence, and the
mortality associated with this disease.
The male predominance demonstrated in this study
was in keeping with previous observations reported in
studies performed elsewhere [12,13]. However, equal
gender distribution was reported in previous studies
from Nigeria [14], and Kenya [15]. The male predomin-
ance in our study can be explained by the fact that most
of the known risk factors for esophageal cancer are
related to behavior - smoking and excessive alcohol
consumption - of which men are known to be worse
consumers than their gender counterparts.
Globally, esophageal cancer has been reported to be
more prevalent in people with low socioeconomic status
Table 3 Anatomical site, macroscopic appearance,




Upper third esophagus 34 10.4
Middle third esophagus 192 58.5
Lower third esophagus 90 27.4
Not documented 12 3.7
Tumor length
≤ 5 cm 132 40.2
>5 cm 185 52.4








Not documented 24 7.3
Histopathological type




Moderately differentiated 184 56.1
Poorly differentiated 40 12.2
Tumor staging
I and II 2 0.6
III and IV 102 31.1




Not documented 82 25.0
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most of patients had either primary education or no
formal education and more than 75% of them were un-
employed. Socioeconomic class appears to be an inde-
pendent risk factor in the development of esophageal
cancer [11,24]. The vast majority of patients in the
present study came from the rural areas located a con-
siderable distance from the study area. A similar obser-
vation was reported by others [14,15]. This finding has
implications for the accessibility to health care facilities
and awareness of the disease.Several risk factors have been implicated in the geo-
graphic variation in the incidence of esophageal cancer
[6-8]. Alcohol and tobacco abuse in the etiology of
esophageal cancer is well-established [15,25,26]. In our
study, history of alcohol consumption and smoking was
documented in 61.6% and 74.7% of patients, respectively.
These figures are significantly higher than the 19.7% and
1.3% respectively, as reported (in northwestern Iran) by
Aledavood et al. [26]. It has been estimated that more
than 80% of esophageal cancer cases in industrialized
countries can be attributed to exposure to these lifestyle
choices, either singly or jointly [15,26]. Substantial alco-
hol intake, especially in combination with smoking,
greatly increases the risk of squamous-cell carcinoma
but not adenocarcinoma. The joint effect of alcohol and
smoking when consumed together are potentiated and
the final relative risk is multiplied [11,15,26].
Family history of esophageal cancer has also been
shown to be relevant in some high-risk areas. A study in
Shanxi Province, China, found that families who have a
prior history of esophageal cancer were significantly
more likely to have reported a new case during 10 years
of follow up [11]. In the present review, family history of
esophageal cancer was reported in 4.6% cases, a figure
significantly lower than the 43% reported by Dawsey
et al. [23]. This finding suggests that genetic factors may
be playing an important role in the development of this
disease in our country. Based on this alarming observa-
tion we suggest that screening programs, especially gen-
etic screening programs, should be considered as a main
measure for prevention and control of esophageal cancer
in this part of the world.
The two most common symptoms present in all our
patients were dysphagia and weight loss which is similar
to previous studies from within and outside Africa
[12,14-16,27]. In this study, all patients presented at an
advanced stage with progressive dysphagia and weight
loss. Dysphagia and weight loss are so commonly associ-
ated that some authors regard them as being pathogno-
monic [15]. Dysphagia is usually associated with bulky
tumors that obstruct the esophageal lumen, impairing its
function and causing pain [12,15]. The absence of serosa
and the distensibility of the esophagus delay the symp-
toms of esophageal cancer until the tumor is advanced.
This could contribute to the variable duration of symp-
toms [28]. The pliability of the esophagus is such that
dysphagia occurs when the lumen is obstructed by about
75% of the circumference, although a small tumor may
cause a tight stenosis through intense fibrosis [15,27,28].
In the present study, the majority of patients presented
late with an advanced stage of cancer, which is in
keeping with other studies in developing countries
[12,14-16]. Most patients in our environment are diag-
nosed at a late stage because of the asymptomatic
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nosis. Late presentation in our study may also be attrib-
uted to lack of awareness of the disease, low standard of
education and lack of accessibility to health care facilities
in this region. Late presentation of cases is an area of
esophageal cancer care in our centre that requires
urgent attention. Detecting esophageal cancer at an early
stage contributes to improve chances for successful
treatment and thus, for survival.
The location of the tumor within the length of the
esophagus varies with the histological type. Squamous
cell carcinoma is commonly found in the middle and
distal third of the esophagus while adenocarcinoma is
more commonly located in the distal third. In this study,
the middle third of the esophagus was the most frequent
anatomical site for esophageal cancer in over 50%
of cases, which is consistent with previous studies
[15,16,26]. Our finding is at variant with other studies
[29-31], which reported the distal third of the esophagus
as the most common site for esophageal cancer. We
could not find reasons in the literature for this anatom-
ical distribution pattern.
Squamous cell carcinoma was the predominant histo-
logical type of esophageal cancer in this study, account-
ing for 96% of cases. This is similar to reports from
other parts of Africa and India in which over 90%
of esophageal cancer are squamous cell carcinomas
[14-16,32]. This contrasts with studies from the US in
which adenocarcinoma accounted for 81% and squa-
mous cell carcinoma for 17% [12]. In another study
among Asian/Pacific Islanders in the US, the rate of
esophageal squamous cell carcinoma was 81% higher
than in white populations [31]. The predominance of
squamous cell carcinoma in this study may be attributed
to the high rate of alcohol consumption and smoking in
this part of Tanzania. The high prevalence of adenocar-
cinoma in Western countries reflects the pathophysi-
ology of the tumor, which has been associated with
gastro-esophageal reflux disease (GERD). In this study,
only three patients showed histological features of Barrett’s
esophagus. Although data from Africa is scant, a review of
GERD in African literature by several workers have
confirmed that overall, there is higher prevalence of GERD
and adenocarcinoma in Western countries than in all
regions of sub-Saharan Africa and that although urba-
nization has increased the risk factors associated with
GERD, the impact of this is yet to be seen.
In the present study, distant metastasis was docu-
mented in 43.3% of cases. A similar distant metastatic
pattern was reported in other studies [14-16]. Late pres-
entation in our area in the majority of patients may also
be responsible for the high distant metastatic rate.
Esophageal cancer in most developing countries, includ-
ing Tanzania, has a dismal prognosis because of theadvanced stage at presentation. The majority of our pa-
tients presented with late-stage disease, making them
inoperable.
The potential limitation of this study is the fact that
information about some patients was incomplete in view
of the retrospective nature of the study. This might have
introduced some bias in our findings. Also TNM staging
was only performed in few patients due to lack of sta-
ging facilities such as EUS, which is used for tumor and
nodal staging, and the irregular availability of CT.
Conclusion
Esophageal cancer is not uncommon in this region,
shows a trend towards a relatively young age at presen-
tation, and the majority of patients present late at an ad-
vanced stage. Lack of awareness of the disease, poor
accessibility to healthcare facilities, lack of diagnostic
and staging facilities, lack of screening programs, poor
accessibility to adjuvant therapy and the high cost of
care are among the hallmarks of the disease in this re-
gion and pose a great challenge in the management of
these patients. Addressing these challenges will help re-
verse this trend.
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